Microsurgical Management of Chronic Cancer-Related Lymphedema
A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Surgical Oncology".
Deadline for manuscript submissions: 30 April 2026 | Viewed by 20
Special Issue Editors
Interests: microsurgery; breast cancer; supermicrosurgical lymphatic reconstruction
Special Issue Information
Dear Colleagues,
Chronic cancer-related lymphedema is a debilitating complication affecting many cancer survivors, significantly impairing quality of life. Microsurgical techniques, such as lymphaticovenous anastomosis (LVA) and vascularized lymph node transfer (VLNT), have emerged as promising treatments to restore lymphatic drainage. However, their widespread adoption remains limited due to technical complexity, variability in long-term outcomes, and the need for specialized surgical expertise.
This Special Issue focuses on advancing the microsurgical management of chronic cancer-related lymphedema. We welcome original research and reviews addressing:
- Surgical innovations (e.g., supermicrosurgery, intraoperative imaging)
- Preoperative planning (Artificial Intelligence, imaging, patient selection)
- Postoperative outcomes (patency rates, volume reduction)
- Patient-reported quality of life (validated assessment tools)
Contributions highlighting multidisciplinary approaches, comparative studies, or novel techniques are particularly encouraged. By consolidating the latest evidence, this issue aims to refine surgical strategies and improve patient care.
We look forward to your contributions.
Prof. Elisabeth A. Kappos
Guest Editor
Dr. Adriano Fabi
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- microsurgery
- chronic cancer-related lymphedema
- lymphatic reconstruction
- surgical techniques
- quality of life
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
